GLUT1 Messenger RNA and Protein Induction Relates to the Malignant Transformation of Cervical Cancer

American Journal of Clinical Pathology

Volumn 120, Issue 5, 2003, Pages 691-698

  Rudlowski, Christian ^a   Becker, Albert J ^b   Schroder, Willibald ^c   Rath, Werner ^a   Büttner, Reinhard ^b   Moser, Markus ^d  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^b UNIVERSITY HOSPITAL BONN   (Germany)

^c Central Hospital   (Germany)

^d MAX PLANCK INSTITUTE OF BIOCHEMISTRY   (Germany)

Author keywords

Cervical neoplasm; Glucose metabolism; GLUT1; HPV; Human papillomavirus

Indexed keywords

ANTIBODY; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 3; GLUCOSE TRANSPORTER 4; MESSENGER RNA;

ARTICLE; CANCER CELL; CANCER GRADING; CANCER RISK; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; EPITHELIUM DYSPLASIA; FEMALE; GENE OVEREXPRESSION; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INVASIVE CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; NONHUMAN; PRECANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INDUCTION; STATISTICAL SIGNIFICANCE; TISSUE SECTION; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX EPITHELIUM; VIRUS TYPING; WART VIRUS;

EID: 0242332098     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/4KYNQM5862JW2GD7     Document Type: Article

References (36)

1. Warburg O. On the origin of cancer cells. Science. 1956;123:309-314.
2. Mueckler M, Caruso C, Baldwin SA, et al. Sequence and structure of a human glucose transporter. Science. 1985;229:941-945.
3. Gould GW, Bell GI. Facilitative glucose transporters: an expanding family. Trends Biochem Sci. 1990;15:18-23.
4. Joost HG, Bell GI, Best JD, et al. Nomenclature of the GLUT/SLC2A family of sugar/polyol transport facilitators. Am J Physiol Endocrinol Metab. 2002;282:E974-E976.
5. Olson AL, Pessin JE. Structure, function, and regulation of the mammalian facilitative glucose transporter gene family. Annu Rev Nutr. 1996;16:235-256.
6. Das DK, Chowdury JR. The use of glycogen studies in the evaluation of treatment for carcinoma of the cervix uteri. Acta Cytol. 1981;25:566-571.
7. Reisser C, Eichhorn K, Herold-Mende C, et al. Expression of facilitative glucose transport proteins during development of squamous cell carcinomas of the head and neck. Int J Cancer. 1999;80:194-198.
8. McMahon RJ, Frost SC. Glycogen: a carbohydrate source for GLUT-1 glycosylation during glucose deprivation of 3T3-L1 adipocytes. Am J Physiol. 1996;270:E640-E645.
9. Birnbaum MJ, Haspel HC, Rosen OM. Transformation of rat fibroblasts by FSV rapidly increases glucose transporter gene transcription. Science. 1987;235:1495-1498.
10. Flier JS, Mueckler MM, Usher P, et al. Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science. 1987;235:1492-1495.
11. Rollins BJ, Morrison ED, Usher P, et al. Platelet-derived growth factor regulates glucose transporter expression. J Biol Chem. 1988;263:16523-16526.
12. Hiraki Y, Rosen OM, Birnbaum MJ. Growth factors rapidly induce expression of the glucose transporter gene. J Biol Chem. 1988;263:13655-13662.
13. Alo PL, Visca P, Botti C, et al. Immunohistochemical expression of human erythrocyte glucose transporter and fatty acid synthase in infiltrating breast carcinomas and adjacent typical/atypical hyperplastic or normal breast tissue. Am J Clin Pathol. 2001;116:129-134.
14. Brown RS, Wahl RL. Overexpression of Glut-1 glucose transporter in human breast cancer: an immunohistochemical study. Cancer. 1993;72:2979-2985.
15. Ahn YS, Zerban H, Grobholz R, et al. Sequential changes in glycogen content, expression of glucose transporters and enzymic patterns during development of clear/acidophilic cell tumors in rat kidney. Carcinogenesis. 1992;13:2329-2334.
16. Nagase Y, Takata K, Moriyama N, et al. Immunohistochemical localization of glucose transporters in human renal cell carcinoma. J Urol. 1995;153:798-801.
17. Tsukamoto H, Hamada Y, Wu D, et al. GLUT1 glucose transporter: differential gene transcription and mRNA binding to cytosolic and polysome proteins in brain and peripheral tissues. Brain Res Mol Brain Res. 1998;58:170-177.
18. Noguchi Y, Marat D, Saito A, et al. Expression of facilitative glucose transporters in gastric tumors. Hepatogastroenterology. 1999;46:2683-2689.
19. Joost HG, Thorens B. The extended GLUT-family of sugar/polyol transport facilitators: nomenclature, sequence characteristics, and potential function of its novel members (review). Mol Membr Biol. 2001;18:247-256.
20. Sugawara Y, Eisbruch A, Kosuda S, et al. Evaluation of FDG PET in patients with cervical cancer. J Nucl Med. 1999;40:1125-1131.
21. Cervix uteri. In: American Joint Committee on Cancer: AJCC Cancer Staging Manual. 5th ed. Philadelphia, PA: Lippincott; 1997:189-194.
22. Moser M, Imhof A, Pscherer A, et al. Cloning and characterization of a second AP-2 transcription factor: AP-2 beta. Development. 1995;121:2779-2788.
23. Feoli-Fonseca JC, Oligny LL, Brochu P, et al. Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach. J Med Virol. 2001;63:284-292.
24. zur Hausen H. Papillomavirus infections: a major cause of human cancers. Biochim Biophys Acta. 1996;1288:F55-F78.
25. Munger K, Phelps WC, Bubb V, et al. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol. 1989;63:4417-4421.
26. Durst M, Dzarlieva-Petrusevska RT, Boukamp P, et al. Molecular and cytogenetic analysis of immortalized human primary keratinocytes obtained after transfection with human papillomavirus type 16 DNA. Oncogene. 1987;1:251-256.
27. Altmann A, Jochmus I, Rosl F. Intra- and extracellular control mechanisms of human papillomavirus infection. Intervirology. 1994;37:180-188.
28. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671-674.
29. Younes M, Lechago LV, Somoano JR, et al. Wide expression of the human erythrocyte glucose transporter Glutl in human cancers. Cancer Res. 1996;56:1164-1167.
30. Maehama T, Patzelt A, Lengert M, et al. Selective down-regulation of human papillomavirus transcription by 2-deoxyglucose. Int J Cancer. 1998;76:639-646.
31. Gherzi R, Melioli G, de Luca M, et al. "HepG2/erythroid/brain" type glucose transporter (GLUT1) is highly expressed in human epidermis: keratinocyte differentiation affects GLUT1 levels in reconstituted epidermis. J Cell Physiol. 1992;150:463-474.
32. Airley R, Loncaster J, Davidson S, et al. Glucose transporter glut-1 expression correlates with tumor hypoxia and predicts metastasis-free survival in advanced carcinoma of the cervix. Clin Cancer Res. 2001;7:928-934.
33. 18F-FDG-PET) in the diagnosis of recurrence and lymph node metastasis of cervical cancer. Oncol Rep. 2000;7:1261-1264.
34. Voldstedlund M, Dabelsteen E. Expression of GLUT1 in stratified squamous epithelia and oral carcinoma from humans and rats. APMIS. 1997;105:537-545.
35. Haber RS, Rathan A, Weiser KR, et al. GLUT1 glucose transporter expression in colorectal carcinoma: a marker for poor prognosis. Cancer. 1998;83:34-40.
36. Younes M, Brown RW, Stephenson M, et al. Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival. Cancer. 1997;80:1046-1051.